From: Impact of delays in radiotherapy of head and neck cancer on outcome
Parameter | HR | 95% CI | P-value |
---|---|---|---|
Locoregional control | |||
TNM (III vs. I-II) | 0.855 | 0.378–1.934 | 0.706 |
TNM (IV vs. I-II) | 2.265 | 1.276–4.021 | 0.005 |
Age | 0.969 | 0.944–0.994 | 0.015 |
TTI | 1.013 | 0.997–1.028 | 0.104 |
Gender | 0.476 | 0.191–1.183 | 0.110 |
Therap (CCT vs. RT) | 1.370 | 0.857–2.189 | 0.188 |
Cause specific hazard | |||
TNM (III vs. I-II) | 0.855 | 0.378–1.934 | 0.026 |
TNM (IV vs. I-II) | 2.265 | 1.276–4.021 | < 0.001 |
Age | 0.979 | 0.961–0.997 | 0.024 |
TTI | 1.003 | 0.991–1.014 | 0.631 |
Gender | 0.827 | 0.483–1.416 | 0.489 |
Therapy (CCT vs. RT) | 1.234 | 0.877–1.736 | 0.228 |